News & Articles
Top new resources to advance your immuno-oncology research
Exclusive interviews, free downloads, the latest methods and much more to help support your immuno-oncology research
Zymo Research obtains CE IVD mark for its Quick SARS-CoV-2 Multiplex Kit
The kit promises to be a low cost, high-sensitivity diagnostic test for COVID-19 detection
PhoreMost and Oxford Biomedica enter gene therapy discovery collaboration
Collaboration to develop next-generation CAR-T cell therapies with improved efficacy and durability
Nucleic acid contamination detection: Protect DNA and RNA samples to ensure downstream accuracy
How the NanoDrop One UV-Vis Spectrophotometer is bringing specificity to UV-Vis measurements
Probabilistic genotyping: The forensic lab software used to crack cold cases
Dr. Bruce Budowle discusses how probabilistic genotyping is helping forensic labs identify low-level, degraded DNA samples
Beckman Coulter launches its Access SARS-CoV-2 IgM assay in countries accepting the CE mark
The new IgM antibody test demonstrated 99.9% specificity with 1,400 negative samples and 100% sensitivity at >18 days post symptom onset and post positive PCR
Easy monochromator for ultraviolet light
EUROIMMUN launches quantitative ELISA to measure SARS-CoV-2 antibodies against viral S1 protein
Underscores importance of serological testing using the S1 subunit for worldwide seroprevalence and vaccine development
High-quality therapeutic antibody generation for the immuno-oncology sector
Discover the importance of high-throughput and robust methodologies for finding ‘needle-in-the-haystack’ therapeutic antibodies
Spectral cytometry software workflows and tools that enable multi-parametric flow cytometry
Join this webinar to discover more about the software and hardware of the new ID7000 spectral analyzer
Low-field NMR of polymer materials: An introduction to characterizing multicomponent polymer systems
Watch this on-demand webinar to learn about the key factors that play a role in the ability of low-field NMR to analyze polymer systems
More than 90% effective: Pfizer and BioNTech announce phase 3 COVID-19 vaccine results
Study enrolled 43,538 participants, with 42% having diverse backgrounds, and no serious safety concerns have been observed; Safety and additional efficacy data continue to be collected
New accessible microscope design opens up understanding of bio-molecules
The microscope aims to give microbiologists a greater insight into how single bio-molecules behave
Combining electronic and photonic chips enables new record in super-fast quantum light detection
Bristol researchers have developed a tiny device that paves the way for higher performance quantum computers and quantum communications
Synthace and Ipsen partner to accelerate novel therapeutic development through automation
Two European leaders in biopharma and integrative software are working together to advance drug discovery